Jason Patrick Meyenburg, President & CEO at Gemini Therapeutics, Inc. /DE (GMTX), bought 26,000 shares at $9.46 ($246K) on 2021-05-14, disclosed to the SEC on 2021-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.46 | 13,000 | $123K | 50.0% |
| 2 | $9.46 | 13,000 | $123K | 50.0% |
| Total | $9.46 avg | 26,000 | $246K | 100% |